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L-Aspartate and L-glutamate are transported into human fibroblast lysosomes by a single, low Kin, Na+-independent 
plasma membrane system x~¢, although these differences have been observed: (!) lysosomal system d recognizes the 
D- as well as the l.-isomers of both aspar~ate and glutamate, whereas only for aspartate is the D-isomer recognized by 
system x~¢; (2) the anion L-homocysteate is not accepted by system x~'~;, but is an effective inhibitor of lysosomai 
system d; (3) N-methyl, a-methyl, and o-hydroxamate derivatives o~ ~,lh aspartate and glutamate inhibit lysosomal 
system d, but only the asparlate derivatives are accepted by system xA-c.; (4) lysosomai system d shows a preference for 
the substrate amino group in the a-position, a preference not seen for system XA¢;. These points imply differences at the 
two recognition sites with respect to substrate length, st:, ~, -.~d rotation, wilh the !yso~oma! site generally being t ~  less 
restrictive. 
Introduction 
Lysosomes are a major site for macromolecule de- 
gradation in the cell. The degradation of proteins m 
lysosomes results in the accumulation of free amino 
acids, which exit the lysosomes through amino acid 
transport systems. Several lysosomal transport systems 
for amino acids have been described in a number of cell 
types, including two systems for large neutral and 
aromatic amino acids [1,2] one for small neutral amino 
acids [3], one for cationic amino acids [4,5], and one for 
cystine [6-9]. Most of these lysosomal transport systems 
are analogous to those amino acid transport systems 
found for the plasma membrane, although some distinct 
differences between the corresponding systems in the 
two locations have been observed (see Refs. 4,5, and 
reviews, Refs. 10 and 11). 
Anionic amino acids are transported across the 
plasma membrane of mammalian cells by at least two 
systems. A Na*-dependent system x,~ G has been char- 
acterized in cat hepatocy~es and human [ibrobiasls wltich 
transports L-aspartate and L-glutamate with approxi- 
mately equal affinities [12-14]. The: renal brush border 
also has a system superficially similar to system x~,G 
[15,16]. A NaLindependent system x c has b e n  char- 
acterized in rat hepatccytes, rat hepatoma cells, and 
human fibroblasts which preferentially transports 
glutamate, homocysteate, and cystine [17-22]. The 
transport of aspartate and glutamate into human 
fibroblast lysosomes is mediated by a system similar to 
system XAG, but which is less restrictive in certain 
aspects of substrate recognition. We report here the 
characterization of this lysosomal system, provisionally 
named lysosomal system d, with the provisional evoca- 
tion, "dicarboxylic'. Preliminary results on lysosomal 
system d have been reported [231. 
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Materials and Methods 
Cell  culture. Normal human fetal skin fibroblasts 
(GM0010) were obtained from the Human Genetic and 
Mutant Cell Repository. The cells were grown in 100- 
mm petri dishes or roller bottles in a 5% CO 2 atmo- 
sphere at 37°C in Coon's modification of Ham's F-12 
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medium (Hazelton Research Products, Inc.), supple- 
mented with 10% fetal calf serum (Hazelton). 
Lysosomal preparation. Lysosomes were prepared as 
described previously [3]. Lysosomes were routinely re- 
suspended in 100 mM citric acid buffered with 1 M Tris 
to pH 7.0 
Transport assays. For time courses, lysosomes were 
resuspended in 100 mM citrate/Tris buffer. Equal 
volumes of the ice-cold lysosome suspension and pre- 
warmed L-[3Hlglutamate (20-40 Ci /mmol)  or L- 
[3H]aspartate (15-40 Ci /mmol)  in 0.25 M sucrose were 
,ncubated at 370C. At the indicated times, an aliquot 
was removed, added to 12 ml ice-cold phosphate- 
buffered saline (PBS), and filtered through a Whatman 
G F / A  glass-fiber filter. The filter was quickly washed 
with two 12-ml washes of ice-cold PBS, then counted 
for radioactivity. Blanks were run using buffer contain- 
ing no lysosomes. An aliquot of the lysosome suspen- 
sion was used to determine lysosomal integrity by mea- 
suring latent /~-hexosaminidase activity [4]. Only rough 
estimates of organelle water are possible at the present 
time, so the convention of expressirJg uptake data as 
pmol amino ac id /uni t  latent fl-hexosaminidase activity 
has been followed. 
For kinetic and inhibition experiments, 15/~1 of the 
3H-labelled amino acid in 0.25 M sucrose, and 15/.tl of 
unlabelled amino acid or inhibitor in 50 mM citrate/  
Tris/0.125 M sucrose buffer (pH 7.0), were added 
together and prewarmed to 37°C. 15 pl of the ice-cold 
lysosome suspension in 100 mM citrate/Tris buffer was 
added with mixing, and 40 ~tl of the resulting suspen- 
sion was removed at 1.5 min, which was then added to 
PBS, filtered, and washed as described above. Kinetic 
parameters were determined using a FORTRAN pro- 
gram {24] applying the Gauss-Newton non-linear least- 
squares method to the following equation 
log o = log{l( Vm~.'S)/(K,.+ S)] + K.~ 'S} 
where K d represents the estimated first-order non- 
saturable component of migration. 
In experiments determining the effect of sodium ions 
on glutamate exodus, the lysosomes were preloaded 
with 2 mM L-[3H]glutamate in I00 mM ci t ra te /Trb  
buffer for 30 min at 37 ° C. They were then pelleted by 
centnfugation and resuspended in the selected pre- 
warmed buffer. The fl-hexosaminidase act vity was de- 
termined promptly after the end of the experiment on 
the lysosomes remaining in the reaction mixt,~"e. 
For trans experiments, lysosomes were pre-loaded in 
50 mM citrate/Tris/0.125 M sucrose buffer containing 
10 mM L-glutamic acid methyl ester for 20 min at 
37°C, then pelleted, resuspended in 100 mM ci t ra te /  
Tris buffer, and used as described above for time courses. 
For a control, the methyl ester was omitted. 
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Fig. 1. Time course of L-glutamate uptake into human fibroblast 
lysosomes. Lysosomes were incubated with 10 p.M L-[3H]glutamate in 
50 mM citrate/Tris buffer containip.~ either 0.125 M sucrose or 0.077 
M NaCt. An aliquot was removed at the indicated times and t:°ated 
as described in Materials and Methods. O, sucrose; II. NaCI. 
nitrophenyl-fl-D-N-acetylglucosaminide were obtained 
from Sigma Chemical Co. Radioactive amino acids were 
obtained from Amersham. Percoll was purchased from 
Pharmacia P-L Biochemicals. 
Results and Discussion 
The time course of 10 ~t~M glutamate uptake into 
lysosomes, in the presence of sucrose or NaCI, is shown 
in Fig. 1. Glutamate upte.~:e appeared to be a Na+ inde -  
pendent process. We als:, measured glutamate exodus 
from lysosomes in the presence of sucrose or NaCI. 
Extralysosomal Na + ions would alter the Na+-ion 
gradient and would red~tce the rate of glutamate exodus 
if exodus were dependent on the gradient. Fig. 2 shows 
the rate of glutamate exodus was not reduced. Both 
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Fig. 2. Exodus of L-glutamate from human fibrob|ast lysosomes. 
Lysosomes were incubated with 2 mM L-[3HIglutamale in 100 mM 
citrate/Tris buffer for 30 rain, the, pelleted. The lysosomes were then 
resuspended in 50 mM citrate/Trls buffer wi!h either 0.125 M sucrose 
or 0.077 M NaCI. The radioactivity remaining in the lysosomes was 
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Fig, 3. Trans-effeCls Orl lysosomal glutamate uptake. Lysosomes were 
incubated with or without 10 mM glutamic acid methyl ester in 50 
mM citrate/Tris/0.125 M sucrose for 20 rain at 37 ° C, then pelleted. 
The lysosomes were then resuspended in 100 mM citrate/Tris buffer 
and incubated with 10/xM t-13H]glutamate in 0.25 M sucrose. At the 
indicated times an aliquot was removed and treated as described in 
Materials and Methods. e, control; It preloaded. 
The effect of intralysosomal glutamate on Na +-inde- 
pendent glutamate uptake was determined by pre-load- 
ing the iysosomes with L-glutamate methyl ester before 
measuring the rate of uptake of 10 btM glutamate (Fig. 
3). Glutamate uptake was not subject to strong trans 
effects. 
The kinetic parameters of Na+-independent gluta- 
mate uptake into lysosomes were determined using ini- 
tial velocities of 1.5 rain. Fig. 4a shows the Eadie- 
Scatchard analysis of these kinetic data. The apparent 
Km values ranged between 4 ~tM and 12 /~M over 
several experiments. The I'm.., ~ values and the values 
representing the non-saturable component varied from 
experiment to experiment (probably because of varia- 
tion in factors such as cell passage number and length 
of time at confluence). The linear plot is consistent with 
glutamate transport being mediated by a single, Na +-in- 
dependent system. 
The kinetic parameters of iysosomal aspartate uptake 
were also determined. The Eadie-Scatchard plot of these 
data is shown in Fig. 4b. The apparent Km values 
ranged between 4 oM and 12 ,.tM over several experi- 
ments. The linear plot suggests that aspartate uptake is 
probably also mediated by a single Na+-independent 
system. 
Fig. 5a shows the double-reciprocal plot of aspartate 
inhibition of lysosomal glutamate uptake. The inhibi- 
tion by aspartate appeared to be competitive, and the 
determined K i value for inhibition was approx. 7 ~M, 
in good agreement with the K m value determined for 
aspartate uptake. Conversely, glutamate inhibition of 
lysosomal aspartate uptake appeared competitive (Fig. 
5b), with agreement between the Km value :or gluta- 
mate uptake and the K, value for glutamate inhibition 
(approx. 5 ~M). Taken together, the kinetic data suggest 
that glutamate and aspartate are transported into lyso- 
somes by a single Na+.independent system, and that 
aspartate and glutamate have approximately equal af- 
finities for this system. Lysosomal system d is, in this 
respect, most closely analogous to the plasma mem- 
brane system x,~<;. 
The effect of pH on Na+-independent aspartate up- 
take into iysosomes was measured (Fig. 6). An ap- 
proximate doubling of activity was seen between pH 5 
and 8. The increase in activity cannot be attributable to 
an increase in the anionic form o f  aspartate, since most 
of the amino acid will already be in the anionic form at 
pH 5. The increase in activity may be the result of 
titration of a group on the transporter, making trans- 
port more efficient at higher pH, or of a pH-dependent 
change in some other parameter, such as an ic,a gradi- 
ent, which then indirectly affects transport. The pH 
inside the lysosome has been estimated at approx. 5.3, 
whereas that of the cytoplasm is closer to 7.0 [25-2'7]. 
Under this pH gradient, net aspartate movement across 
the lysosomal membrane would be directed inward. The 
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Fig. 4. Eadie-Scatchard plots of L-glutamate and L-aspattate uptake into human fibroblast tysosomcs. (A) The uptake of L-g lu t ama te  at  various 
concentrations was determined. A non-saturable component of O.161 pmol/he't/min/mM was subtracted from each data point. K~ = 9 ~tM _ 0.7 
for this experiment. (B) The uptake of t-asparlate at various concentrations w is determined. A non-saturable component of 0.161 pmol/hex/min/ 

















-200 o 200 400 
1 / [g tu ]  ( rnM"  ] 




1 0 0 - -  
, 
0 
-200 -100  0 '00 200 
Fig. 5. D0uble-reciprocal plots demonstrating competitive inhibition between L-aspanate and t-glutamate for lysosomal transport. (A) Inhibition of 
L-glutamate uptake into human fibroblast lysosomes by L-aspartate. Aspartate concentrations were: @, control (Km for glutamate uptake = 3.6 
I'M + 1.5): o. 0.01 raM: l ,  0.05 raM; n, 0.10 mM. (B) Inhibition of L-aspartate uptake into human fibroblast iysosomes by L-glutamate. Glutamate 
concentrations were: e, control (Kin for aspartate uptake = 3.8 t~M+ 1.9); o, 0.005 raM; I ,  0.015 raM; n, 0.050 raM. 
several other factors, including the routes and rates of 
exodus and entry, and the concentrations of glutamate 
and aspartate in the ' . . . . . . . . .  ,2 . . . .  and the intracellular 
compartment [28,29]. 
Wc looked at a range of amino acids and amino acid 
analogs as inhibitors of Na+-independent glutamate 
uptake to characterize the substrate specificity of the 
lysosomal anionic transport system (Table I). Aspartate, 
cysteine sulfinate, cysteate, homocysteate, and L-a- 
aminoadipate were very effective inhibitors. The longer 
D,L-a-aminopimelate showed less inhibition. Both the 
L-aspartate and the L-glutamate hydroxamate deriva. 
tives inhibited lysosomal glutamate uptake, the aspar- 
tate derivative being the more effective. In contrast, the 
glutamate hydroxamate derivative is ineffective as an 
inhibitor of system x~. G [14]. The chain length limita- 
tion for lysosomal system d is, therefore, slightly longer 
than that for system XAG. Cystine, however, is too long, 
if not improperly charged, for both systems. 
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Fig. 6. The effect of pH on aspartate uptake into human fibroblast 
lysosomes. Lysosomes were resuspended in 0.25 M st-crose and in- 
cubated in 10 raM Mops (pH 5.0-6.5) or Mes (pH 6.5-8.0) buffers 
with 10 FM L-[3H]aspartate and 0.25 M sucrose for 1.5 min at 37 c C, 
An aliquot was then removed and treated as described in Materials 
and Methods. Points are the averages of three determinations, rhe 
error bars represent standard deviations. 
Homocysteate, which has a bulky sulfonate group at 
the distal anion site, inhibited lysosomal system d but 
does not inhibit system x~G [14]. This suggests that the 
lysosomal recognition site for the distal anion is less 
TABLE I 
Inhibition o] glutamate uptake by amino acids and analogs 
Glutamate uptake (10 #M) was determined in the presence of 10 mM 
inhibitor, unless otherwise indicated. The data are expressed as per- 
centages of the uninhibited glutamate uptake rate. The values repre- 
sent the averages of two determinations, with the ranges indicated in 
parentheses, The table combines the results of several experiments, in 
which control glutamate uptake values ranged between 0.06 and IA 
pmol per unit latent hexosaminida~e activity. 
Inhibitor 7o control 
L-Aspartal¢ 0 
D-Aspartate 21 (20- 21) 
L-C~steinesulfinate 0 
L-Cysteate I1 (9- 13) 
L-Glutamate 0 
D-Glutamate 33 (29- 36) 
L-Hornocysteate 21 (20- 21) 
L-a-Aminoadipate 8 (8- 8) 
p-a-Aminoadipate 67 (57- 77) 
D,L-a-Aminopimelate 76 (71- 80) 
L-Aspartate-//-hydroxamate 3 (2- 4) 
t-Ghitamate-,/-hydroxamate 29 (28- 29) 
t.-Cystine (0,2 mM) 107 (105-109) 
N-Methyl-L-aspartate 51 (50- 52) 
N-MethyI-D-aspartate 15 (15- 15) 
N-Methyl-L-glutamate 64 (61- 68) 
a-MethyI-D,L-aspartate 48 (47- 49) 
a-MethyI-D,L-glutamate 34 (31- 36) 
N-Acetyi-L-aspartate 27 (20- 35) 
N-Acetyi-L-glutamate 105 (98-113) 
3-Aminoglutarate 76 (72- 80) 
a-L-AspanyI-L-atanine 53 0 2 -  54) 
fl-L-Aspartyl-L-alanine 33 (32- 34) 
Kainate 79 (78- 80) 
L-Leucine 91 (80-103) 
L-Serine 93 (89- 97) 
2-Me0,ylaminoisobutyrie acid 122 (120-124) 
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restrictive than its plasma membrane counterpart. The 
N-methyl- and a-methyl-derivatives of both aspartate 
and glutamate inhibited lysosomal glutamate uptake by 
approx. 50%, whereas only the aspartate analogs are 
effective as inhibitors of system x~c [!4]. These find- 
ings suggest that the lysosomai recognitior, sites for the 
a-carbon and the a-amino group are also larger or more 
tolerant than the plasma membrane sites, although the 
longer glutama:e cannot be accommodated when its 
amino group is acetylated. 
The stereospecificity of lysosomal system d is al:~o 
less restrictive than that seen for system x.~ o. The L- 
and D-isomers of aspartate are ti'ansported by s2~stem 
x~, c ,  but only L-glutamate, and not D-glutamate, is 
accepted. In contrast, the D-isomers of both aspartate 
and glutamate inhibited lysosomai glutamate uptake, 
although they were not quite as effective as the L-iso- 
mers. These results imply that lysosomal system d can 
accommodate more variation than system x~, o in the 
length of the two groups on the a-carbon on either side 
of the a-amino group. There is a limit to this accep- 
tance, since D-a-aminoadipate, with a longer butyrate 
group on one side o[ the a-carbon, has become a less 
effective inhibitor than L-a-aminoadipate. 
3-Aminoglutarate, which has a / l -amino group, hardly 
inhibited lysosomal glutamate uptake, although it is a 
strong inhibitor of system x ~ .  The dipeptide/~-L-Asp- 
L-AIa, although restricted in its acceptance by its length, 
is a better inhibitor of lysosomal system d than the 
dipeptide a-L-Asp-L-AIa. These results suggest that 
lysosomal system d, unlike system x~,o, has a prefer- 
ence for the substrate amine group in the a-position. 
The cyclic glutamate analogue, kainate, which is used 
to discriminate excitatory amino acid receptors in the 
central nervous system [30,31], hardly inhibited gluta- 
mate uptake at all, in contrast to its effectiveness as an 
inhibitor for system xl, c .  This was the only-case ob- 
served in which lysosomal system d was the less tolerant 
system as to substrate size or conformation. 
In summary, we have characterized a lysosomal 
transport system for anionic amino acids, provisionally 
named lysosomal system d. This system is similar to the 
plasma membrane system XAG ia that the natural sub- 
strates, L-aspartate and L-glutamate, appear to be trans- 
ported by lysosomal system d with approximately equal 
and relatively high affinities. It is, however, less restric- 
tive than system x~G with respect to substrate length, 
size, and rotation. The plasma membrane system xT,,~ is 
sodium dependent, whereas the data presented here 
indicated th~.t both uptake and exodus through lyso- 
somal system d are sodium independean. There is, 
however, little information available about the distribu- 
tion and flows of Na + ions across the lysosomal mem- 
brane, and technical difficulties in determining ion dis- 
tribution prohibit us from exploring this aspect of lyso- 
somal transport further at this time. A sys!em annie- 
gous to system x~ has not been detected for the 
lysosome, a~thoagh such a system would be per'dnent to 
cystinosis [10.11 ]. 
Other characterized iysosomal trar~sport systems also 
show features that distinguish them from the roughly 
corresponding amino acid transport systems of the 
plasma membrane [10,1 ..]. The transport system defect 
in cysfinosis is restricted to the lysosomes, since cystine 
transport at the plasma membrane is unaltered [32], 
suggesting, in this case, that the transporters at the two 
sites are genetically disti , : t .  For most cases, however, 
the question as to whether the agencies for amino acid 
transport at the two Ioca::ons are products of different 
genes or not ,'emains unanswered. 
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